[Dangers of a too rapid substitution of imipramine for an inhibitor of monoamine oxidase and of the nialamide-isoniazid-barbiturate combination at high doses in psychiatric therapy].
D000328:Adult; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D001463:Barbiturates / Q000009:adverse effects; D001921:Brain / Q000187:drug effects; D001923:Brain Chemistry; D002395:Catecholamines / Q000032:analysis; D002415:Cats; D003863:Depression / Q000188:drug therapy*; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000032:analysis; D007099:Imipramine / Q000009:adverse effects*; D007538:Isoniazid / Q000009:adverse effects; D009206:Myocardium / Q000032:analysis; D009526:Nialamide / Q000009:adverse effects / Q000627:therapeutic use*; D009638:Norepinephrine / Q000032:analysis; D011817:Rabbits; D051381:Rats; D013154:Spleen / Q000032:analysis
D001463:Barbiturates; D002395:Catecholamines; D007099:Imipramine; D009526:Nialamide; D007538:Isoniazid; D009638:Norepinephrine
Dangers de la substitution trop rapide de l'imipramine à un inhibiteur de la mono-amine-oxydase et de l'association nialamide-isoniazide-barbituriques à doses élevées en thérapeutique psychiatrique.